| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |